REGIMENS

作品数:142被引量:264H指数:8
导出分析报告
相关领域:医药卫生更多>>
相关作者:于锋葛卫红魏艳红邵宏孔维华更多>>
相关机构:东南大学中国药科大学南京大学医学院附属鼓楼医院国家知识产权局更多>>
相关期刊:更多>>
相关基金:国家自然科学基金广东省自然科学基金更多>>
-

检索结果分析

结果分析中...
选择条件:
  • 期刊=Journal of Clinical and Translational Hepatologyx
条 记 录,以下是1-3
视图:
排序:
Efficacy and Safety of Sofosbuvir-based Regimens in Hepatitis C Patients With Decompensated Cirrhosis:A Systematic Review and Meta-analysis被引量:3
《Journal of Clinical and Translational Hepatology》2023年第1期144-155,共12页Wenyan Zhang Jing Zhang Shan Tang Yali Liu Xiaofei Du Lixia Qiu Menglu Liu Haibin Yu Calvin Q.Pan 
supported by a research grant from the Capital health development research project (grant number:2020-1-3011);a grant from the Beijing Youan Hospital,Capital Medical University in 2018 (grant number:YNKTTS20180105);a grant from the Beijing Municipal Administration of Hospitals Incubating Program in 2018 (grant number:PX2018058).
Background and Aims:Decompensated cirrhotic patients with hepatitis C(HCV)are often under-represented in clinical trials.We aimed to evaluate pooled data on the efficacy and safety of sofosbuvir(SOF)-based regimens in...
关键词:Direct-acting antiviral HCV liver failure Sustained virologic response RIBAVIRIN 
Direct-acting Antiviral Regimens for Patients with Chronic Infection of Hepatitis C Virus Genotype 3 in China被引量:4
《Journal of Clinical and Translational Hepatology》2021年第3期419-427,共9页Xiaozhong Wang Lai Wei 
Hepatitis C virus(HCV)genotype(GT)3 infection is associated with a more rapid hepatic disease progression than the other genotypes.Hence,early HCV clearance slows down the disease progression and is important for impr...
关键词:CIRRHOSIS Direct-acting antivirals Hepatitis C Genotype 3 Resistance-associated substitutions 
Sofosbuvir-based Regimens with Task Shifting Is Cost-effective in Expanding Hepatitis C Treatment Access in the United States
《Journal of Clinical and Translational Hepatology》2017年第1期16-22,共7页Channa R.Jayasekera Rachel Beckerman Nathaniel Smith Ryan B.Perumpail Robert J.Wong Zobair M.Younossi Aijaz Ahmed 
Background and Aims:The current paradigm of specialist physician-managed treatment of chronic hepatitis C virus infection(HCV)is inefficient in absorbing the approximately 3 million patients awaiting treatment in the ...
关键词:Hepatitis C Treatment access Task shifting Cost effectiveness 
检索报告 对象比较 聚类工具 使用帮助 返回顶部